287 related articles for article (PubMed ID: 20730418)
1. Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination.
van Nieuwenhuijzen PS; Long LE; Hunt GE; Arnold JC; McGregor IS
Psychopharmacology (Berl); 2010 Dec; 212(4):663-74. PubMed ID: 20730418
[TBL] [Abstract][Full Text] [Related]
2. Weekly gamma-hydroxybutyrate exposure sensitizes locomotor hyperactivity to low-dose 3,4-methylenedioxymethamphetamine in rats.
van Nieuwenhuijzen PS; Li KM; Hunt GE; McGregor IS
Neuropsychobiology; 2009; 60(3-4):195-203. PubMed ID: 19893336
[TBL] [Abstract][Full Text] [Related]
3. A long hangover from party drugs: residual proteomic changes in the hippocampus of rats 8 weeks after γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination.
van Nieuwenhuijzen PS; Kashem MA; Matsumoto I; Hunt GE; McGregor IS
Neurochem Int; 2010 Jul; 56(8):871-7. PubMed ID: 20227452
[TBL] [Abstract][Full Text] [Related]
4. Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.
van Nieuwenhuijzen PS; McGregor IS
Drug Alcohol Depend; 2009 Aug; 103(3):137-47. PubMed ID: 19446408
[TBL] [Abstract][Full Text] [Related]
5. Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats.
Clemens KJ; Cornish JL; Hunt GE; McGregor IS
Drug Alcohol Depend; 2007 Jan; 86(2-3):183-90. PubMed ID: 16884865
[TBL] [Abstract][Full Text] [Related]
6. Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes.
McGregor IS; Gurtman CG; Morley KC; Clemens KJ; Blokland A; Li KM; Cornish JL; Hunt GE
Psychopharmacology (Berl); 2003 Aug; 168(4):465-74. PubMed ID: 12700882
[TBL] [Abstract][Full Text] [Related]
7. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?
McGregor IS; Callaghan PD; Hunt GE
Br J Pharmacol; 2008 May; 154(2):358-68. PubMed ID: 18475254
[TBL] [Abstract][Full Text] [Related]
8. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat.
Clemens KJ; Van Nieuwenhuyzen PS; Li KM; Cornish JL; Hunt GE; McGregor IS
Psychopharmacology (Berl); 2004 May; 173(3-4):318-25. PubMed ID: 15029472
[TBL] [Abstract][Full Text] [Related]
9. Intermittent ethanol exposure increases long-lasting behavioral and neurochemical effects of MDMA in adolescent mice.
Rodríguez-Arias M; Maldonado C; Vidal-Infer A; Guerri C; Aguilar MA; Miñarro J
Psychopharmacology (Berl); 2011 Nov; 218(2):429-42. PubMed ID: 21556804
[TBL] [Abstract][Full Text] [Related]
10. Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood.
Cohen MA; Skelton MR; Schaefer TL; Gudelsky GA; Vorhees CV; Williams MT
Synapse; 2005 Sep; 57(3):148-59. PubMed ID: 15945064
[TBL] [Abstract][Full Text] [Related]
11. Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity.
Bull EJ; Hutson PH; Fone KC
Neuropharmacology; 2004 Feb; 46(2):202-10. PubMed ID: 14680758
[TBL] [Abstract][Full Text] [Related]
12. MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635.
Hunt GE; McGregor IS; Cornish JL; Callaghan PD
Brain Res Bull; 2011 Aug; 86(1-2):65-73. PubMed ID: 21745546
[TBL] [Abstract][Full Text] [Related]
13. Distinct periods of developmental sensitivity to the effects of 3,4-(±)-methylenedioxymethamphetamine (MDMA) on behaviour and monoamines in rats.
Skelton MR; Graham DL; Schaefer TL; Grace CE; Braun AA; Burns LN; Amos-Kroohs RM; Williams MT; Vorhees CV
Int J Neuropsychopharmacol; 2012 Jul; 15(6):811-24. PubMed ID: 21733225
[TBL] [Abstract][Full Text] [Related]
14. Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy").
Morley KC; Gallate JE; Hunt GE; Mallet PE; McGregor IS
Eur J Pharmacol; 2001 Dec; 433(1):91-9. PubMed ID: 11755138
[TBL] [Abstract][Full Text] [Related]
15. Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats.
Thompson MR; Li KM; Clemens KJ; Gurtman CG; Hunt GE; Cornish JL; McGregor IS
Neuropsychopharmacology; 2004 Apr; 29(4):694-704. PubMed ID: 14627999
[TBL] [Abstract][Full Text] [Related]
16. Increased Response to 3,4-Methylenedioxymethamphetamine (MDMA) Reward and Altered Gene Expression in Zebrafish During Short- and Long-Term Nicotine Withdrawal.
Ponzoni L; Teh MT; Torres-Perez JV; Brennan CH; Braida D; Sala M
Mol Neurobiol; 2021 Apr; 58(4):1650-1663. PubMed ID: 33236326
[TBL] [Abstract][Full Text] [Related]
17. Behavioral sensitization to 3,4-methylenedioxymethamphetamine is long-lasting and modulated by the context of drug administration.
Ball KT; Klein JE; Plocinski JA; Slack R
Behav Pharmacol; 2011 Dec; 22(8):847-50. PubMed ID: 21979834
[TBL] [Abstract][Full Text] [Related]
18. Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats.
Thompson MR; Callaghan PD; Hunt GE; McGregor IS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1013-21. PubMed ID: 18302974
[TBL] [Abstract][Full Text] [Related]
19. Oxytocin and MDMA ('Ecstasy') enhance social reward in rats.
Ramos L; Hicks C; Caminer A; Goodwin J; McGregor IS
Psychopharmacology (Berl); 2015 Jul; 232(14):2631-41. PubMed ID: 25772337
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram.
Piper BJ; Fraiman JB; Owens CB; Ali SF; Meyer JS
Neuropsychopharmacology; 2008 Apr; 33(5):1192-205. PubMed ID: 17609680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
